Expired Tender USA ICB TOT Ref. 3269088

Expand the bone marrow screening program Tender in USA - 3269088

Tender notice from USA, published on 15 Jul 2015.

Executive Summary

The DEPARTMENT OF THE NAVY has issued a Tender notice for the procurement of a Expand the bone marrow screening program and continue to improve the typing resolution and accuracy by continuing improvements in the solid phase based system paired with dna sequencing for hla in support of naval medical research center, silver spri in the USA. This Tender notice was published on 15 Jul 2015 and is scheduled to close on 28 Jul 2015, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 3269088, while the tender notice number is N32398BONEMARROW and Register on the platform.

Key facts

Summary
Expand the bone marrow screening program and continue to improve the typing resolution and accuracy by continuing improvements in the solid phase based system paired with dna sequencing for hla in support of naval medical research center, silver spri
TOT Ref. No.
3269088
Document Ref. No.
N32398BONEMARROW
Country
USA
Notice type
Tender
Competition
ICB
Publication date
15 Jul 2015
Bid deadline
28 Jul 2015
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The naval medical logistics command (nmlc) intends to award a sole source contract under the authority of far 6.302-1 to one lambda, incorporation (inc.), 21001 kittridge street, canoga park, ca 91303-2801; for the performance of a research and development (r&d) project in support of the naval medical research center (nmrc), silver spring md. The estimated period of performance of the project is 12 months.
The research project will support the department of defense (dod) in expanding the bone marrow screening program and continuing to improve the typing resolution and accuracy by continuing improvements in the solid phase (bead) based system paired with deoxyribonucleic acid (dna) sequencing for human leukocyte antigen (hla). The objective is to develop an hla typing system for donors that allow transplant centers searching for matched donors to identify these positively through complete allele level data on the search files used by the nmrc program to support potential patients and causalities of marrow toxic exposure.
One lambda, inc. Is the only source that has developed a high resolution (hd) rsso (reverse sequence-specific oligonucleotide) dna typing reagents in the labtype product family and accompanying in vitro diagnostic medical devices (ivd) analysis software (hla fusion). The collaboration of one lambda, inc. With nmrc since 2007 has been successful in continuing to develop specific probes to improve assay resolution and to meet the typing requirements of the dod hla typing program and bone marrow registry under the c.w. Bill young marrow donor program.
One lambda inc. Is the only source that will continue to develop and manufacture new sso typing kits to support nmrc donor recruitment hla-a, hla-b, hla-c, hla-drb, hla-dqb1 and hla-dpab alleles to detect and discriminate between alleles found in the dod bone marrow donor pool, even if they are rare in the general population. One lambda will use 2 patents assigned by the u.s. Patent office to continue this research. Further, one lambda, inc. Is the only source who will continue to use the solid phase bead system and be paired with dna sequencing capable of simultaneously analyzing multiple hla loci as referenced above. This requires extensive use of both of one lambda s patents, exclusive license, and proprietary technology providing testing of tens of thousands of unique samples at research level genetic testing (allele level) with federal laboratory certification. One lambda inc. Will continue to develop and hla test library preparation protocols and integration of existing nmrc automation equipment so that the software will be consistent with products being delivered. Further, given its patents, one lambda, inc. Is the only company who can continue to develop dna primer pairs and sequence the 3.6 mb region of major histocompatibility complex genes from hla-a to hla-dp and incorporate technology from this study into the existing proprietary bed/sequencing system used by nmrc to improve genetic matching for marrow transplantation. A sources sought notice was issued on 08 july 2015 for this requirement and the government determined after the review of capability statements, that no other source had the capability to perform the required work.
This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 1 (8.5 x 11 inch) page and shall be submitted in 12 point, times new roman font. All capability statements received by the due date of this notice will be considered by the government. A request for documentation or additional information will not be considered as an affirmative response. A determination by the government not to compete based on responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 5:00 pm local time, july 28, 2015. Capability statements shall be submitted by e-mail only as a microsoft word or adobe pdf attachment to the following address: [email protected].
503 robert grant avenue

silver spring, maryland 20910

united states
primary point of contact.:

ronald stephen sanford

[email protected]

phone: 301-619-9330 general information
a -- research & development

naics code:

541 -- professional, scientific, and technical services/541711 -- research and development in biotechnology
541 -- professional, scientific, and technical services/541711 -- research and development in biotechnology

for help: federal service deskaccessibility

added: jul 13, 2015 1:23 pm

Documents

Tender Notice
Login to view

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Husky Terminal115KVBABATransformer USA 152585607 05 Jan 2027
Big Bend Road from US 41 to Covington Garden Dr. USA 152585603 05 Jan 2027
Painting Services- As Needed USA 152585597 08 Dec 2026
Ocean Ridge Reclaimed Waterline USA 152585575 10 Dec 2026
Purchase the Old Westmoreland Fire Station #8 USA 152585574 09 Dec 2026

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Expand the bone marrow screening program and continue to improve the typing resolution and accuracy by continuing improvements in the solid phase based system paired with dna sequencing for hla in support of naval medical research center, silver spri was 28 Jul 2015. Bidding is closed.

This tender has been issued by DEPARTMENT OF THE NAVY in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 45252123 - Screening installations.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 3269088. The purchaser document reference is N32398BONEMARROW.

See the Similar Tenders section on this page or browse other tenders from USA.

This tender falls under Construction and Real Estate in USA. Suppliers in these sectors can track similar USA tenders using CPV-based alerts.